Sulfadiazine

DRUG2 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID)

Conditions

HIV InfectionsToxoplasmosisToxoplasmosis, Cerebral

Phase 2

Phase II Randomized Open-Label Trial of Atovaquone Plus Pyrimethamine and Atovaquone Plus Sulfadiazine for the Treatment of Acute Toxoplasmic Encephalitis

CompletedNCT00000794

National Institute of Allergy and Infectious Diseases (NIAID)Toxoplasmosis, Cerebral, HIV Infections

End: 1998-04-30Target: 100Updated: 2021-10-28

Phase 4

Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis

RecruitingNCT00004317

National Institute of Allergy and Infectious Diseases (NIAID)Toxoplasmosis

Start: 2000-07-31End: 2030-12-31Target: 600Updated: 2009-05-14

Related Papers

Prematurity and severity are associated with Toxoplasma gondii alleles (NCCCTS, 1981-2009).

2012-04-11116 citations